Literature DB >> 25132755

Natural history of chronic hepatitis B: phases in a complex relationship.

Catherine M N Croagh1, John S Lubel1.   

Abstract

Chronic hepatitis B (CHB) is a condition of global prevalence and its sequelae include cirrhosis and hepatocellular carcinoma. The natural history of CHB is a complex interplay of virological, environmental and host factors. The dynamic relationship between the virus and host evolves over the duration of the infection and different phases of the disease have been observed and described. These have been conceptualized in terms of the state of balance between the host immune system and the hepatitis B virus and have been given the labels immune tolerant, immune clearance, immune control and immune escape although other nomenclature is also used. Host factors, such as age at infection, determine progression to chronicity. Virological factors including hepatitis B viral load, mutations and genotype also have an impact on the adverse outcomes of the infection, as do hepatotoxic cofactors such as alcohol. Our understanding of the natural history of CHB has evolved significantly over the past few decades and characterizing the phase of disease of CHB remains an integral part of managing this virus in the clinic.

Entities:  

Keywords:  Cirrhosis; Fibrosis; Genotype; Hepatitis B; Hepatitis B e antigen; Hepatocellular carcinoma; Liver; Natural history

Mesh:

Substances:

Year:  2014        PMID: 25132755      PMCID: PMC4130846          DOI: 10.3748/wjg.v20.i30.10395

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  79 in total

Review 1.  Hepatitis B e antigen-negative chronic hepatitis B.

Authors:  S J Hadziyannis; D Vassilopoulos
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

2.  Chronic hepatitis B.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

3.  Relation of Australia-SH antigen to the willowbrook MS-2 strain.

Authors:  J P Giles; R W McCollum; L W Berndtson; S Krugman
Journal:  N Engl J Med       Date:  1969-07-17       Impact factor: 91.245

4.  Pregnancy and chronic hepatitis B virus infection.

Authors:  Swati Sinha; Manoj Kumar
Journal:  Hepatol Res       Date:  2010-01       Impact factor: 4.288

5.  Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

Authors:  M-F Yuen; H-J Yuan; D K-H Wong; J C-H Yuen; W-M Wong; A O-O Chan; B C-Y Wong; K-C Lai; C-L Lai
Journal:  Gut       Date:  2005-05-04       Impact factor: 23.059

6.  Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.

Authors:  S J Hadziyannis; H M Lieberman; G G Karvountzis; D A Shafritz
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

7.  Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis.

Authors:  R P Perrillo; C R Campbell; G E Sanders; F G Regenstein; C J Bodicky
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

8.  Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.

Authors:  F Bonino; F Rosina; M Rizzetto; R Rizzi; E Chiaberge; R Tardanico; F Callea; G Verme
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

9.  Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.

Authors:  Yi-Cheng Chen; Chia-Ming Chu; Yun-Fan Liaw
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

10.  Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.

Authors:  Tony Andreani; Lawrence Serfaty; Djamila Mohand; Salem Dernaika; Dominique Wendum; Olivier Chazouillères; Raoul Poupon
Journal:  Clin Gastroenterol Hepatol       Date:  2007-04-11       Impact factor: 11.382

View more
  31 in total

Review 1.  Virus-induced hepatocellular carcinoma with special emphasis on HBV.

Authors:  Ming Wang; Dong Xi; Qin Ning
Journal:  Hepatol Int       Date:  2017-01-17       Impact factor: 6.047

2.  Decreased frequency of circulating Th9 cells in patients with chronic hepatitis B infection.

Authors:  Meilan Cui; Ying Lv; Jianhua Lu; Wei Zhang; Yuanyuan Duan; Yan Huang; Lei Yang; Man Li; Wenxuan Liu; Dianwu Liu; Huimin Yan
Journal:  J Clin Lab Anal       Date:  2017-05-08       Impact factor: 2.352

3.  Conservative Evolution of Hepatitis B Virus Precore and Core Gene During Immune Tolerant Phase in Intrafamilial Transmission.

Authors:  Yuqian Luo; Le Zhang; Yimin Dai; Yali Hu; Biyun Xu; Yi-Hua Zhou
Journal:  Virol Sin       Date:  2020-03-02       Impact factor: 4.327

Review 4.  Optimizing antiviral agents for hepatitis B management in malignant lymphomas.

Authors:  Oluwatobi O Ozoya; Julio Chavez; Lubomir Sokol; Samir Dalia
Journal:  Ann Transl Med       Date:  2017-02

5.  Association of Nucleostemin Polymorphisms with Chronic Hepatitis B Virus Infection in Chinese Han Population.

Authors:  Jixia Li; Jinya Xu; Yangui Wang; Qin Li; Xilian Sun; Wen Fu; Bo Zhang
Journal:  Genet Test Mol Biomarkers       Date:  2022-05-16

Review 6.  Is hemodialysis a reason for unresponsiveness to hepatitis B vaccine? Hepatitis B virus and dialysis therapy.

Authors:  Dede Sit; Bennur Esen; Ahmet Engin Atay; Hasan Kayabaşı
Journal:  World J Hepatol       Date:  2015-04-18

Review 7.  Better plans and more powerful evidence are needed in the research and treatment of chronic hepatitis B in China.

Authors:  Changtai Zhu; Yulu Gao; Lihui Jiang; Baoqiong Ding; Yongning Sun
Journal:  Int J Clin Exp Med       Date:  2015-12-15

8.  Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B.

Authors:  Rengang Huang; Nan Jiang; Renguo Yang; Xiaoxia Geng; Jianmei Lin; Gang Xu; Dandan Liu; Jidog Chen; Guo Zhou; Shuqiang Wang; Tingting Luo; Jiazhen Wu; Xiaoshu Liu; Kaiju Xu; Xingxiang Yang
Journal:  Exp Ther Med       Date:  2016-03-09       Impact factor: 2.447

9.  Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya.

Authors:  Mark K Webale; Mark W Kilongosi; Valentine Budambula; Raphael Lihana; Francis O Musumba; Anthony K Nyamache; Nancy L M Budambula; Aabid A Ahmed; Collins Ouma; Tom Were
Journal:  BMC Infect Dis       Date:  2015-07-30       Impact factor: 3.090

10.  Predictive Factors in the Incidence of Cirrhosis in Chronic Hepatitis B Virus Infections.

Authors:  Seyed Moayed Alavian; Mohammad Hadi Imanieh; Mohammad Hossein Imanieh
Journal:  Hepat Mon       Date:  2016-05-03       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.